Evli Maailma B vs UBS Lux Equity Fund Biotech USD

Evli Maailma B vs UBS Lux Equity Fund Biotech USD

1. Evli Maailma B

  • Security

    Evli Maailma B

  • Fee

    1.61%

  • ISIN

    FI0008801188

  • Holdings

    6

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 6 holdings in Evli Maailma B, where the largest holding is Betsson (2.7), followed by Allison Transmission (2.42) and Ahold Delhaize (2.3). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Evli Maailma B and UBS Lux Equity Fund Biotech USD.

Evli Maailma B UBS Lux Equity Fund Biotech USD
1. Betsson B
2.7 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Allison Transmission Holdings Inc
2.42 %
2. Moderna Inc
9.21 %
3. Ahold Delhaize NV
Netherlands
2.3 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Cencora Inc
USA
2.16 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Dropbox Inc
USA
2.12 %
5. AbbVie Inc
USA
4.91 %
6. Bunzl Plc
UK
1.87 %
6. Gilead Sciences Inc
USA
4.66 %
- 7. Amgen Inc
USA
4.43 %
- 8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %

The list of fund holdings was last updated on July 26, 2025.